Are there any shortfalls in the desired therapeutic profile and if so, how will these be addressed?

Yes, two have been recognised in the interest of compliance. Firstly, there is the requirement for the daily dose of fosmidomycin to be reduced by at least 50% from the current level of 60mg/kg. Secondly, there is the need to achieve a once daily dosing regimen not exceeding three days.

Go back